TreeWAS – Variant ID: rs1110701

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.970	0.030
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.973	0.026
S06 Intracranial injury	0.000	0.976	0.024
S06.4 Epidural haemorrhage	0.000	0.977	0.023
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.977	0.022
S06.0 Concussion	0.000	0.978	0.022
S06.2 Diffuse brain injury	0.000	0.979	0.021
S06.00 Concussion (without open intracranial wound)	0.000	0.980	0.020
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.000	0.981	0.019
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.981	0.019
S06.7 Intracranial injury with prolonged coma	0.000	0.982	0.018
S06.1 Traumatic cerebral oedema	0.000	0.982	0.018
S06.5 Traumatic subdural haemorrhage	0.000	0.983	0.017
S06.41 Epidural haemorrhage (with open intracranial wound)	0.000	0.983	0.017
S06.9 Intracranial injury, unspecified	0.000	0.983	0.017
S06.3 Focal brain injury	0.000	0.984	0.016
S02.10 Fracture of base of skull (closed)	0.000	0.984	0.016
S06.8 Other intracranial injuries	0.000	0.984	0.016
S06.01 Concussion (with open intracranial wound)	0.000	0.984	0.016
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.985	0.015
S02.1 Fracture of base of skull	0.000	0.986	0.014
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.000	0.987	0.013
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.000	0.987	0.013
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.000	0.987	0.013
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.000	0.987	0.013
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.987	0.013
S02 Fracture of skull and facial bones	0.000	0.988	0.012
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.988	0.012
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.000	0.988	0.012
S02.0 Fracture of vault of skull	0.000	0.988	0.012
S02.00 Fracture of vault of skull (closed)	0.000	0.988	0.012
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.988	0.012
S06.81 Other intracranial injuries (with open intracranial wound)	0.000	0.988	0.012
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.988	0.012
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.989	0.011
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.989	0.011
S02.8 Fractures of other skull and facial bones	0.000	0.989	0.010
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.990	0.010
S02.7 Multiple fractures involving skull and facial bones	0.000	0.990	0.010
S02.6 Fracture of mandible	0.000	0.990	0.010
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.990	0.010
J92.9 Pleural plaque without asbestos	0.010	0.990	0.000
S02.11 Fracture of base of skull (open)	0.000	0.990	0.010
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.990	0.010
T85.3 Mechanical complication of other ocular prosthetic devices, imnplants and grafts	0.010	0.990	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.991	0.009
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.991	0.009
S02.60 Fracture of mandible (closed)	0.000	0.991	0.009
S02.01 Fracture of vault of skull (open)	0.000	0.991	0.009
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.991	0.008
K05.3 Chronic periodontitis	0.000	0.992	0.008
S02.4 Fracture of malar and maxillary bones	0.000	0.992	0.008
S42.20 Fracture of upper end of humerus (closed)	0.008	0.992	0.000
Y45.2 Propionic acid derivatives	0.008	0.992	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.992	0.008
Z22.3 Carrier of other specified bacterial diseases	0.000	0.992	0.008
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.992	0.008
J84.8 Other specified interstitial pulmonary diseases	0.000	0.992	0.008
S02.61 Fracture of mandible (open)	0.000	0.992	0.008
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.008	0.992	0.000
J84 Other interstitial pulmonary diseases	0.000	0.993	0.007
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
S02.5 Fracture of tooth	0.000	0.993	0.007
T42.4 Benzodiazepines	0.007	0.993	0.000
Y45.8 Other analgesics and antipyretics	0.007	0.993	0.000
S02.3 Fracture of orbital floor	0.000	0.993	0.006
Y45.0 Opioids and related analgesics	0.007	0.993	0.000
C44.1 Skin of eyelid, including canthus	0.000	0.993	0.007
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.006	0.994	0.000
Y45.5 4-Aminophenol derivatives	0.006	0.994	0.000
S00-S09 Injuries to the head	0.000	0.994	0.006
Y45.4 Antirheumatics	0.006	0.994	0.000
Z22 Carrier of infectious disease	0.000	0.994	0.006
C26.0 Intestinal tract, part unspecified	0.006	0.994	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.994	0.005
J84.0 Alveolar and parietoalveolar conditions	0.000	0.994	0.005
S02.2 Fracture of nasal bones	0.000	0.995	0.005
S02.51 Fracture of tooth (open)	0.000	0.995	0.005
Z22.5 Carrier of viral hepatitis	0.000	0.995	0.005
R70.0 Elevated erythrocyte sedimentation rate	0.000	0.995	0.005
S42.2 Fracture of upper end of humerus	0.005	0.995	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.995	0.005
J92 Pleural plaque	0.005	0.995	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.005	0.995	0.000
S02.31 Fracture of orbital floor (open)	0.000	0.995	0.005
L71.9 Rosacea, unspecified	0.000	0.995	0.005
Y45.1 Salicylates	0.005	0.995	0.000
Z22.8 Carrier of other infectious diseases	0.000	0.995	0.005
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.005	0.995	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.005	0.995	0.000
E80.4 Gilbert's syndrome	0.005	0.995	0.000
S42.21 Fracture of upper end of humerus (open)	0.004	0.995	0.000
S08 Traumatic amputation of part of head	0.000	0.995	0.004
S07 Crushing injury of head	0.000	0.995	0.004
S04 Injury of cranial nerves	0.000	0.995	0.004
L92.0 Granuloma annulare	0.004	0.995	0.000
Z22.9 Carrier of infectious disease, unspecified	0.000	0.996	0.004
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.996	0.004
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.996	0.004
Z22.2 Carrier of diphtheria	0.000	0.996	0.004
Z22.0 Carrier of typhoid	0.000	0.996	0.004
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.004	0.996	0.000
J92.0 Pleural plaque with presence of asbestos	0.004	0.996	0.000
S03 Dislocation, sprain and strain of joints and ligaments of head	0.000	0.996	0.004
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.996	0.004
S02.21 Fracture of nasal bones (open)	0.000	0.996	0.004
R45.8 Other symptoms and signs involving emotional state	0.000	0.996	0.004
H44.2 Degenerative myopia	0.004	0.996	0.000
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.004	0.996	0.000
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.004	0.996	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.996	0.004
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.996	0.004
R82.9 Other and unspecified abnormal finding in urine	0.004	0.996	0.000
M10.96 Gout, unspecified (Lower leg)	0.004	0.996	0.000
S42.30 Fracture of shaft of humerus (closed)	0.004	0.996	0.000
S04.9 Injury of unspecified cranial nerve	0.000	0.996	0.003
S04.8 Injury of other cranial nerves	0.000	0.996	0.003
S04.7 Injury of accessory nerve	0.000	0.996	0.003
S04.6 Injury of acoustic nerve	0.000	0.996	0.003
S04.5 Injury of facial nerve	0.000	0.996	0.003
S04.4 Injury of abducent nerve	0.000	0.996	0.003
S04.3 Injury of trigeminal nerve	0.000	0.996	0.003
S04.2 Injury of trochlear nerve	0.000	0.996	0.003
S04.1 Injury of oculomotor nerve	0.000	0.996	0.003
S04.0 Injury of optic nerve and pathways	0.000	0.996	0.003
S07.9 Crushing injury of head, part unspecified	0.000	0.996	0.003
S07.8 Crushing injury of other parts of head	0.000	0.996	0.003
S07.1 Crushing injury of skull	0.000	0.996	0.003
S07.0 Crushing injury of face	0.000	0.996	0.003
S08.9 Traumatic amputation of unspecified part of head	0.000	0.996	0.003
S08.8 Traumatic amputation of other parts of head	0.000	0.996	0.003
S08.1 Traumatic amputation of ear	0.000	0.996	0.003
S08.0 Avulsion of scalp	0.000	0.996	0.003
S02.50 Fracture of tooth (closed)	0.000	0.997	0.003
S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head	0.000	0.997	0.003
S03.4 Sprain and strain of jaw	0.000	0.997	0.003
S03.3 Dislocation of other and unspecified parts of head	0.000	0.997	0.003
S03.0 Dislocation of jaw	0.000	0.997	0.003
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.003	0.997	0.000
S03.1 Dislocation of septal cartilage of nose	0.000	0.997	0.003
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
R82 Other abnormal findings in urine	0.003	0.997	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.003	0.997	0.000
S42.3 Fracture of shaft of humerus	0.003	0.997	0.000
S03.2 Dislocation of tooth	0.000	0.997	0.003
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
H92.0 Otalgia	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
K29.1 Other acute gastritis	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.003	0.997	0.000
L71 Rosacea	0.000	0.997	0.003
J02.9 Acute pharyngitis, unspecified	0.000	0.997	0.003
E80 Disorders of porphyrin and bilirubin metabolism	0.003	0.997	0.000
M10.99 Gout, unspecified (Site unspecified)	0.003	0.997	0.000
M20.3 Other deformity of hallux (acquired)	0.003	0.997	0.000
H02.4 Ptosis of eyelid	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
S02.30 Fracture of orbital floor (closed)	0.001	0.997	0.002
Y40 Systemic antibiotics	0.003	0.997	0.000
S42 Fracture of shoulder and upper arm	0.003	0.997	0.000
M10.9 Gout, unspecified	0.003	0.997	0.000
N76.4 Abscess of vulva	0.003	0.997	0.000
Y83.9 Surgical procedure, unspecified	0.000	0.997	0.003
L71.1 Rhinophyma	0.000	0.997	0.003
R82.1 Myoglobinuria	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium	0.000	0.997	0.003
C26 Malignant neoplasm of other and ill-defined digestive organs	0.003	0.997	0.000
J93.9 Pneumothorax, unspecified	0.000	0.997	0.003
E80.1 Porphyria cutanea tarda	0.002	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.003	0.997	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.002	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.002	0.997	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.002	0.997	0.000
R82.3 Haemoglobinuria	0.002	0.997	0.000
R82.2 Biliuria	0.002	0.997	0.000
R82.0 Chyluria	0.002	0.997	0.000
S42.31 Fracture of shaft of humerus (open)	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Z99.1 Dependence on respirator	0.002	0.998	0.000
K05 Gingivitis and periodontal diseases	0.000	0.998	0.002
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
S42.1 Fracture of scapula	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
M10.94 Gout, unspecified (Hand)	0.002	0.998	0.000
E80.2 Other porphyria	0.002	0.998	0.000
L71.8 Other rosacea	0.000	0.998	0.002
L71.0 Perioral dermatitis	0.000	0.998	0.002
R82.4 Acetonuria	0.002	0.998	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
E80.5 Crigler-Najjar syndrome	0.002	0.998	0.000
E80.3 Defects of catalase and peroxydase	0.002	0.998	0.000
E80.0 Hereditary erythropoietic porphyria	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
E80.6 Other disorders of bilirubin metabolism	0.002	0.998	0.000
S42.8 Fracture of other parts of shoulder and upper arm	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
M10.98 Gout, unspecified (Other)	0.002	0.998	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M10.91 Gout, unspecified (Shoulder region)	0.002	0.998	0.000
S42.7 Multiple fractures of clavicle, scapula and humerus	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
M31.6 Other giant cell arteritis	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
E85.9 Amyloidosis, unspecified	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
C26.8 Overlapping lesion of digestive system	0.002	0.998	0.000
C26.1 Spleen	0.002	0.998	0.000
K05.0 Acute gingivitis	0.000	0.998	0.002
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.002	0.998	0.000
C26.9 Ill-defined sites within the digestive system	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
K05.1 Chronic gingivitis	0.000	0.998	0.002
T40.2 Other opioids	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
C21.0 Anus, unspecified	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
M10.92 Gout, unspecified (Upper arm)	0.002	0.998	0.000
S09 Other and unspecified injuries of head	0.000	0.998	0.002
K11.5 Sialolithiasis	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
Z45.1 Adjustment and management of infusion pump	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity	0.000	0.998	0.002
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
D11.0 Parotid gland	0.000	0.998	0.002
K05.2 Acute periodontitis	0.000	0.998	0.002
K05.4 Periodontosis	0.000	0.998	0.002
R94.3 Abnormal results of cardiovascular function studies	0.002	0.998	0.000
S42.9 Fracture of shoulder girdle, part unspecified	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
S42.11 Fracture of scapula (open)	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.000	0.998	0.002
N39.9 Disorder of urinary system, unspecified	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
K62.3 Rectal prolapse	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
N49.2 Inflammatory disorders of scrotum	0.000	0.998	0.002
S42.81 Fracture of other parts of shoulder and upper arm (open)	0.002	0.998	0.000
S42.80 Fracture of other parts of shoulder and upper arm (closed)	0.002	0.998	0.000
O69.1 Labour and delivery complicated by cord around neck, with compression	0.000	0.998	0.002
X41.9 Unspecified place	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y84.6 Urinary catheterisation	0.000	0.998	0.002
M10.97 Gout, unspecified (Ankle and foot)	0.002	0.998	0.000
S42.71 Multiple fractures of clavicle, scapula and humerus (open)	0.002	0.998	0.000
E85.3 Secondary systemic amyloidosis	0.000	0.998	0.002
I47.9 Paroxysmal tachycardia, unspecified	0.000	0.998	0.002
W29.9 Unspecified place	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.002	0.998	0.000
S05 Injury of eye and orbit	0.000	0.998	0.002
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
E85.4 Organ-limited amyloidosis	0.000	0.998	0.002
J04.0 Acute laryngitis	0.000	0.998	0.002
M93.9 Osteochondropathy, unspecified	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
H44 Disorders of globe	0.002	0.998	0.000
S12.10 Fracture of second cervical vertebra (closed)	0.000	0.998	0.002
K05.5 Other periodontal diseases	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
S72.20 Subtrochanteric fracture (closed)	0.002	0.998	0.000
F52.2 Failure of genital response	0.000	0.998	0.002
S09.7 Multiple injuries of head	0.000	0.998	0.002
S09.2 Traumatic rupture of ear drum	0.000	0.998	0.002
S09.1 Injury of muscle and tendon of head	0.000	0.998	0.002
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
W19.3 Sports and athletics area	0.000	0.998	0.002
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.998	0.000
H44.0 Purulent endophthalmitis	0.002	0.998	0.000
K05.22 Aggressive periodontitis, generalized	0.000	0.998	0.001
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
E85 Amyloidosis	0.000	0.998	0.002
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
S42.91 Fracture of shoulder girdle, part unspecified (open)	0.001	0.998	0.000
Y58.0 BCG vaccine	0.001	0.998	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.998	0.002
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
J02 Acute pharyngitis	0.000	0.998	0.002
H44.8 Other disorders of globe	0.002	0.998	0.000
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.000	0.998	0.001
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
F10.4 Withdrawal state with delirium	0.000	0.998	0.002
S05.7 Avulsion of eye	0.000	0.998	0.001
S05.4 Penetrating wound of orbit with or without foreign body	0.000	0.998	0.001
S09.8 Other specified injuries of head	0.000	0.998	0.001
H18.6 Keratoconus	0.002	0.998	0.000
I49.9 Cardiac arrhythmia, unspecified	0.002	0.998	0.000
J02.8 Acute pharyngitis due to other specified organisms	0.000	0.998	0.001
O34.1 Maternal care for tumour of corpus uteri	0.000	0.998	0.002
W29.5 Trade and service area	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.001	0.998	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.001	0.998	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.001	0.998	0.000
H44.3 Other degenerative disorders of globe	0.001	0.998	0.000
Y53.4 Other laxatives	0.001	0.998	0.000
H44.5 Degenerated conditions of globe	0.001	0.998	0.000
S42.0 Fracture of clavicle	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.001	0.998	0.000
W29 Contact with other powered hand tools and household machinery	0.002	0.998	0.000
R70.1 Abnormal plasma viscosity	0.000	0.998	0.001
S09.0 Injury of blood vessels of head, not elsewhere classified	0.000	0.998	0.001
S42.4 Fracture of lower end of humerus	0.001	0.998	0.000
T23.2 Burn of second degree of wrist and hand	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.001	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.998	0.000
Y46.5 Valproic acid	0.001	0.998	0.000
Y46.3 Deoxybarbiturates	0.001	0.998	0.000
Y46.1 Oxazolidinediones	0.001	0.998	0.000
Y46.0 Succinimides	0.001	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.001	0.998	0.000
J02.0 Streptococcal pharyngitis	0.000	0.998	0.001
R23.4 Changes in skin texture	0.000	0.998	0.002
E07.9 Disorder of thyroid, unspecified	0.002	0.998	0.000
E85.8 Other amyloidosis	0.000	0.998	0.001
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.998	0.001
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.998	0.001
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.998	0.001
G50.0 Trigeminal neuralgia	0.000	0.998	0.002
S05.6 Penetrating wound of eyeball without foreign body	0.000	0.998	0.001
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.001	0.998	0.000
I70.0 Atherosclerosis of aorta	0.001	0.998	0.000
H92 Otalgia and effusion of ear	0.001	0.998	0.000
Y43 Primarily systemic agents	0.001	0.998	0.000
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.999	0.001
H44.9 Disorder of globe, unspecified	0.001	0.999	0.000
S05.5 Penetrating wound of eyeball with foreign body	0.000	0.999	0.001
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.000	0.999	0.001
T23.3 Burn of third degree of wrist and hand	0.000	0.999	0.001
Y52.1 Calcium-channel blockers	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
M10 Gout	0.001	0.999	0.000
S42.90 Fracture of shoulder girdle, part unspecified (closed)	0.001	0.999	0.000
Z40.8 Other prophylactic surgery	0.001	0.999	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.999	0.001
Y40.0 Penicillins	0.001	0.999	0.000
Y43.0 Antiallergic and antiemetic drugs	0.001	0.999	0.000
H44.4 Hypotony of eye	0.001	0.999	0.000
H92.2 Otorrhagia	0.001	0.999	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.001	0.999	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.000	0.999	0.001
S05.9 Injury of eye and orbit, part unspecified	0.000	0.999	0.001
Y43.1 Antineoplastic antimetabolites	0.001	0.999	0.000
Z74.2 Need for assistance at home and no other household member able to render care	0.000	0.999	0.001
S42.01 Fracture of clavicle (open)	0.001	0.999	0.000
D75.8 Other specified diseases of blood and blood-forming organs	0.001	0.999	0.000
Q82.8 Other specified congenital malformations of skin	0.001	0.999	0.000
W29.8 Other specified place	0.001	0.999	0.000
W29.6 Industrial and construction area	0.001	0.999	0.000
W29.0 Home	0.001	0.999	0.000
W29.7 Farm	0.001	0.999	0.000
W29.4 Street and highway	0.001	0.999	0.000
W29.3 Sports and athletics area	0.001	0.999	0.000
W29.2 School, other institution and public administrative area	0.001	0.999	0.000
W29.1 Residential institution	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Z99.2 Dependence on renal dialysis	0.001	0.999	0.000
M93.1 Kienbock's disease of adults	0.001	0.999	0.000
R85.7 Abnormal histological findings	0.001	0.999	0.000
Z94.7 Corneal transplant status	0.001	0.999	0.000
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.000	0.999	0.001
S12.1 Fracture of second cervical vertebra	0.000	0.999	0.001
I70.01 Atherosclerosis of aorta (with gangrene)	0.001	0.999	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.000	0.999	0.001
H18.5 Hereditary corneal dystrophies	0.001	0.999	0.000
H44.1 Other endophthalmitis	0.001	0.999	0.000
Y43.9 Primarily systemic agent, unspecified	0.001	0.999	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.001	0.999	0.000
Y43.6 Enzymes, not elsewhere classified	0.001	0.999	0.000
Y43.5 Acidifying and alkalising agents	0.001	0.999	0.000
Y43.2 Antineoplastic natural products	0.001	0.999	0.000
O43.1 Malformation of placenta	0.001	0.999	0.000
S05.8 Other injuries of eye and orbit	0.000	0.999	0.001
Z49.0 Preparatory care for dialysis	0.001	0.999	0.000
S42.41 Fracture of lower end of humerus (open)	0.001	0.999	0.000
M10.4 Other secondary gout	0.001	0.999	0.000
M10.3 Gout due to impairment of renal function	0.001	0.999	0.000
M10.2 Drug-induced gout	0.001	0.999	0.000
M10.1 Lead-induced gout	0.001	0.999	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.999	0.001
W21.0 Home	0.001	0.999	0.000
G96.0 Cerebrospinal fluid leak	0.001	0.999	0.000
H11.9 Disorder of conjunctiva, unspecified	0.000	0.999	0.001
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.000	0.999	0.001
W29.09 Contact with other powered hand tools and household machinery; Home; During unspecified activity	0.001	0.999	0.000
W29.62 Contact with other powered hand tools and household machinery; Industrial and construction area ;While working for income	0.001	0.999	0.000
W29.82 Contact with other powered hand tools and household machinery; Other specified places ;While working for income	0.001	0.999	0.000
D11.7 Other major salivary glands	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations